Compare Kyndryl Holdings Inc (KD) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kyndryl Holdings Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Kyndryl Holdings Inc trades at $12.19 (market cap $2.69B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 26.2× Kyndryl Holdings Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.
| KD | REGN | |
|---|---|---|
Market Cap | $2.69B | $70.47B |
Sector | Technology | Health |
52-Week High | $39.47 | $812.27 |
52-Week Low | $10.59 | $545.46 |
Enterprise Value | $5.03B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
